Long-Term Safety and Tolerability of the Oral Direct Renin Inhibitor Aliskiren with Optional Add-On Hydrochlorothiazide in Patients with Hypertension: A Randomized, Open-Label, Parallel-Group, Multicentre, Dose-Escalation Study with an Extension Phase

By Sica Domenic  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 825-837

Adis International

Access to resources Recommend Favorite

A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human α_v integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer

By Chu Franklin   Picus Joel   Fracasso Paula   Dreicer Robert   Lang Zhihui   Foster Brenda  

Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. : 674-679

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of Anorectal Nifedipine and Lidocaine (Lignocaine) Ointment following Haemorrhoidectomy: An Open-Label, Single-Dose, Phase IV Clinical Study

By Perrotti Pasquale  

Clinical Drug Investigation, Vol. 29, Iss. 4, 2009-01 ,pp. : 243-256

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Cinacalcet in Hepatic Impairment: Phase I, Open-Label, Parallel-Group, Single-Dose, Single-Centre Study

By Padhi Desmond  

Clinical Drug Investigation, Vol. 28, Iss. 10, 2008-01 ,pp. : 635-643

Adis International

Access to resources Recommend Favorite

Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study

By Kipnes Mark S.  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 51-61

Adis International

Access to resources Recommend Favorite